ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,246Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 137

$679K Total Retail Price of All Prescriptions

Rank: 8 out of 137

1,122 Patients Receiving at Least One Drug in Part D
92% Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Oklahoma
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
SIMVASTATIN 762 701 202 1 9
CARVEDILOL 640 568 160 2 2
AMLODIPINE BESYLATE 634 594 164 3 5
CLOPIDOGREL 632 583 140 4 1
LISINOPRIL 541 493 157 5 3
WARFARIN SODIUM 390 347 110 6 10
FUROSEMIDE 372 336 101 7 7
CRESTOR 315 272 70 8 14
ATORVASTATIN CALCIUM 299 269 78 9 4
SPIRONOLACTONE 297 282 88 10 18
METOPROLOL TARTRATE 295 283 85 11 8
SOTALOL 261 256* 64 12 30
METOPROLOL SUCCINATE 222 217* 56 13 6
CLONIDINE HCL 210 190 49 14 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 200 184 48 15 35
BISOPROLOL FUMARATE 188 183* 51 16 58
AMIODARONE HCL 187 182* 59 17 19
HYDROCHLOROTHIAZIDE 187 182* 51 17 16
PRAVASTATIN SODIUM 184 166 47 19 11
TRIAMTERENE-HCTZ 169 164* 49 20 79
ATENOLOL 168 149 45 21 17
LOSARTAN POTASSIUM 162 157* 46 22 15
FLECAINIDE ACETATE 148 130 33 23 46
BISOPROLOL-HYDROCHLOROTHIAZIDE 124 119* 31 24 122
BYSTOLIC 119 114* 35 25 26
DIOVAN 116 104 24 26 23
LOSARTAN-HYDROCHLOROTHIAZIDE 111 106* 34 27 55
VYTORIN 102 97* 25 28 75
ZETIA 102 97* 29 28 32
POTASSIUM CHLORIDE 90 85* 26 30 12
OMEPRAZOLE 89 78 26 31 27
PANTOPRAZOLE SODIUM 85 80* 16 32 37
ENALAPRIL MALEATE 85 80* 22 32 34
LEVOTHYROXINE SODIUM 81 76* 24 34 21
DOXAZOSIN MESYLATE 78 78 21 35 67
PROPRANOLOL HCL 76 76 18 36 106
BENAZEPRIL HCL 71 71 18 37 92
FENOFIBRATE* 63 52 15 38 42
RAMIPRIL 61 <11 <11 39 40
ZOLPIDEM TARTRATE 60 60 17 40 48
NITROSTAT 57 52* 44 41 25
MULTAQ 57 41 13 41 53
AMLODIPINE BESYLATE-BENAZEPRIL 55 50* 12 43 66
ALPRAZOLAM 52 <11 <11 B 44 41
PRADAXA 52 47* 14 44 29
XARELTO 50 <11 <11 46 24
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.